THE TRIUMPH OF DR. DRUKER.
The article looks at Dr. Brian Druker, focusing on his efforts to develop medication for cancer patients. The author comments on Druker's background at the Dana-Farber Cancer Institute and also mentions how his devotion to cancer treatment research led to his divorce. The effects of chemotherapy on...
| Publicado en: | Smithsonian Vol. 42; no. 2; pp. 54 - 64 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Smithsonian Magazine
May2011
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=60122386&site=ehost-live header: @attributes: shortDbName: hlh uiTerm: 60122386 longDbName: Humanities International Complete uiTag: AN controlInfo: bkinfo: jinfo: jid: 00377333 SMI jtl: Smithsonian issn: 00377333 maglogo: N pubinfo: dt: May2011 vid: 42 iid: 2 pid: 359 pub: Smithsonian Magazine artinfo: ui: 60122386 ppf: 54 ppct: 10 formats: fmt: @attributes: type: T tig: atl: THE TRIUMPH OF DR. DRUKER. aug: au: MONMANEY, TERENCE su: Druker, Brian Cancer treatment Drug therapy Clinical drug trials Leukocytes Lopossa, LaDonna Dana-Farber Cancer Institute United States. Food & Drug Administration United States sug: subj: United States Druker, Brian Cancer treatment Drug therapy Clinical drug trials Leukocytes Lopossa, LaDonna Dana-Farber Cancer Institute United States. Food & Drug Administration ab: The article looks at Dr. Brian Druker, focusing on his efforts to develop medication for cancer patients. The author comments on Druker's background at the Dana-Farber Cancer Institute and also mentions how his devotion to cancer treatment research led to his divorce. The effects of chemotherapy on white blood cells is discussed, noting how the drug STI571 does not damage healthy cells. The author comments on how Druker directly sought the approval of the U.S. Food and Drug Administration to begin human trials for the drug. LaDonna Lopossa, a cancer patient who benefited from trials of STI571, is also mentioned. pubtype: Periodical doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y custom: Copyright of Smithsonian is the property of Smithsonian Magazine and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. item: Smithsonian holder: Smithsonian Magazine dt: @attributes: year: 2011 holdings: @attributes: islocal: N |
|---|